Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Large B-Cell Lymphoma.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03440567
What this trial is testing

Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Ended earlyNCT00906841
What this trial is testing

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
French Innovative Leukemia Organisation 75
Testing effectiveness (Phase 2)UnknownNCT00039156
What this trial is testing

BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Theradex
Not applicableLooking for participantsNCT06131801
What this trial is testing

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Who this might be right for
Hematologic MalignancyLeukemiaLymphoma+16 more
Children's Hospital Medical Center, Cincinnati 30
Testing effectiveness (Phase 2)UnknownNCT03629873
What this trial is testing

Efficacy and Safety of Chi-BEAC Combining With Auto-HSCT to Treat Aggressive Lymphoma Subjects

Who this might be right for
Lymphoma, Large B-Cell, DiffuseMantle Cell LymphomaPeripheral T Cell Lymphoma+1 more
The First Affiliated Hospital with Nanjing Medical University 69
Testing effectiveness (Phase 2)Study completedNCT00003575
What this trial is testing

Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT02900651
What this trial is testing

Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 139
Early research (Phase 1)Ended earlyNCT00103272
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more
National Cancer Institute (NCI) 74
Large-scale testing (Phase 3)Study completedNCT00003595
What this trial is testing

Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 120
Early research (Phase 1)Study completedNCT02431988
What this trial is testing

Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation

Who this might be right for
Diffuse Large B-Cell Lymphoma
University College, London 10
Testing effectiveness (Phase 2)Study completedNCT00864227
What this trial is testing

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 54
Testing effectiveness (Phase 2)UnknownNCT05498259
What this trial is testing

Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University 46
Early research (Phase 1)Study completedNCT01943682
What this trial is testing

Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more
Children's Hospital Medical Center, Cincinnati 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565417
What this trial is testing

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Non Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaTriple Negative Breast Cancer+9 more
Immunitas Therapeutics 67
Early research (Phase 1)Looking for participantsNCT07570017
What this trial is testing

Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL
Guangzhou Lupeng Pharmaceutical Company LTD. 42
Not applicableStudy completedNCT04697160
What this trial is testing

Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
MorphoSys AG 3,573
Testing effectiveness (Phase 2)UnknownNCT00032149
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Trials Office 30
Large-scale testing (Phase 3)Looking for participantsNCT05018520
What this trial is testing

The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 640
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Next Page